Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading
cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive …

Chronic low-grade inflammation in adipose tissue (AT) is a hallmark of obesity and
contributes to various metabolic disorders, such as type 2 diabetes and cardiovascular …

Atherosclerosis, characterized by lipid‐rich plaques in the arterial wall, is an age‐related
disorder and a leading cause of mortality worldwide. However, the specific mechanisms …

Obesity reaches up to epidemic proportions globally and increases the risk for a wide
spectrum of co-morbidities, including type-2 diabetes mellitus (T2DM), hypertension …

Microplastics (MP), tiny plastic particles, can be ingested by fish through their habitat or
contaminated food sources. When combined with a high-fat diet (HFD), MP exposure may …

The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome pathway is
mainly responsible for the activation and release of a cascade of proinflammatory mediators …

Inflammatory cytokines have been implicated as crucial contributors to the onset and
progression of non-alcoholic fatty liver disease (NAFLD). The exact mechanisms by which …

Resveratrol, a natural polyphenol in various plants, has gained significant attention for its
potential health‐promoting properties. It has been demonstrated, after reviewing various …

Obesity is becoming an increasing problem worldwide and is often, but not invariably,
associated with dyslipidemia. The gut microbiota is increasingly linked to cardiovascular …

Abstract Purpose of Review This review evaluates the therapeutic potential of Ziziphus
jujuba and its main components in managing complications of metabolic syndrome …